RADNOR, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney ...
– Management to host virtual KOL event today to discuss the unmet need in hypertension, as well as a review of the ongoing pivotal clinical program for lorundrostat in hypertension – RADNOR, Pa., Oct.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する